Search - tctmd.com

Displaying 361 - 380 of 382

Sort: Relevancy | Date

News Daily News

ARISTOTLE Makes Its Case: Apixaban Noninferior to Warfarin in A-fib

June 24, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

Syntax Score Predicts 1-Year Risk in ACS Patients

June 06, 2011

News Daily News

Substantial Decline Seen in CABG Over Last Decade, But PCI Rates Unchanged

L.A. McKeown

May 03, 2011

News Daily News

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Leah Lawrence

April 26, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

News Daily News

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

L.A. McKeown

April 07, 2011

News Daily News

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Caitlin E. Cox

March 25, 2011

News Daily News

Study Compares Stents, Surgery in Diabetics with Multivessel Disease

Caitlin E. Cox

March 23, 2011

News Daily News

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

March 21, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

March 01, 2011

News Daily News

Paclitaxel-Eluting Balloon Effective for DES Restenosis

February 22, 2011

News Daily News

Improvements in Care for PCI Patients with PAD Fail to Budge Mortality, MI Rates

February 07, 2011

News Daily News

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

January 18, 2011

News Daily News

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

January 17, 2011

News Daily News

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

Jason Kahn

January 12, 2011

News Daily News

Researchers Accurately Predict Who Will Discontinue Clopidogrel

Jason Kahn

January 09, 2011

News Daily News

Insurance Type Affects Outcomes After PCI

L.A. McKeown

January 06, 2011

Advertisement

ARISTOTLE Makes Its Case: Apixaban Noninferior to Warfarin in A-fib

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Syntax Score Predicts 1-Year Risk in ACS Patients

Substantial Decline Seen in CABG Over Last Decade, But PCI Rates Unchanged

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

Pioglitazone Can Decrease Need for Revascularization in Diabetic Patients After BMS

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Study Compares Stents, Surgery in Diabetics with Multivessel Disease

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

Studies Support DES Use in Diabetics, But Results Vary by Device

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

Paclitaxel-Eluting Balloon Effective for DES Restenosis

Improvements in Care for PCI Patients with PAD Fail to Budge Mortality, MI Rates

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

Researchers Accurately Predict Who Will Discontinue Clopidogrel

Insurance Type Affects Outcomes After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content